Document detail
ID

oai:pubmedcentral.nih.gov:7643...

Topic
Research Articles
Author
Dastidar, Somasish Ghosh Pham, Michael T. Mitchell, Matthew B. Yeom, Steven G. Jordan, Sarah Chang, Angela Sopher, Bryce L. La Spada, Albert R.
Langue
en
Editor

Society for Neuroscience

Category

The Journal of Neuroscience

Year

2020

listing date

12/12/2022

Keywords
control parkinson quality activation proteins primary protein 4e-bp1 stress misfolded 4e-bp1-overexpressing mitochondrial unfolded response neurons disease
Metrics

Abstract

Decline of protein quality control in neurons contributes to age-related neurodegenerative disorders caused by misfolded proteins.

4E-BP1 is a key node in the regulation of protein synthesis, as activated 4E-BP1 represses global protein translation.

Overexpression of 4E-BP1 mediates the benefits of dietary restriction and can counter metabolic stress, and 4E-BP1 disinhibition on mTORC1 repression may be neuroprotective; however, whether 4E-BP1 overexpression is neuroprotective in mammalian neurons is yet to be fully explored.

To address this question, we generated 4E-BP1-overexpressing transgenic mice and confirmed marked reductions in protein translation in 4E-BP1-overexpressing primary neurons.

After documenting that 4E-BP1-overexpressing neurons are resistant to proteotoxic stress elicited by brefeldin A treatment, we exposed primary neurons to three different Parkinson's disease (PD)-linked toxins (rotenone, maneb, or paraquat) and documented significant protection in neurons from newborn male and female 4E-BP1-OE transgenic mice.

We observed 4E-BP1-dependent upregulation of genes encoding proteins that comprise the mitochondrial unfolded protein response, and noted 4E-BP1 overexpression required activation of the mitochondrial unfolded protein response for neuroprotection against rotenone toxicity.

We also tested whether 4E-BP1 could prevent α-synuclein neurotoxicity by treating 4E-BP1-overexpressing primary neurons with α-synuclein preformed fibrils, and we observed marked reductions in α-synuclein aggregation and neurotoxicity, thus validating that 4E-BP1 is a powerful suppressor of PD-linked pathogenic insults.

Our results indicate that increasing 4E-BP1 expression or enhancing 4E-BP1 activation can robustly induce the mitochondrial unfolded protein response and thus could be an appealing strategy for treating a variety of neurodegenerative diseases, including especially PD.

SIGNIFICANCE STATEMENT In neurodegenerative disease, misfolded proteins accumulate and overwhelm normal systems of homeostasis and quality control.

One mechanism for improving protein quality control is to reduce protein translation.

Here we investigated whether neuronal overexpression of 4E-BP1, a key repressor of protein translation, can protect against misfolded protein stress and toxicities linked to Parkinson's disease, and found that 4E-BP1 overexpression prevented cell death in neurons treated with brefeldin A, rotenone, maneb, paraquat, or preformed fibrils of α-synuclein.

When we sought the basis for 4E-BP1 neuroprotection, we discovered that 4E-BP1 activation promoted the mitochondrial unfolded protein response.

Our findings highlight 4E-BP1 as a therapeutic target in neurodegenerative disease and underscore the importance of the mitochondrial unfolded protein response in neuroprotection against various insults.

Dastidar, Somasish Ghosh,Pham, Michael T.,Mitchell, Matthew B.,Yeom, Steven G.,Jordan, Sarah,Chang, Angela,Sopher, Bryce L.,La Spada, Albert R., 2020, 4E-BP1 Protects Neurons from Misfolded Protein Stress and Parkinson's Disease Toxicity by Inducing the Mitochondrial Unfolded Protein Response, Society for Neuroscience

Document

Open Open

Share

Source

Articles recommended by ES/IODE AI

Visual Verity in AI-Generated Imagery: Computational Metrics and Human-Centric Analysis
image ai human camera-generated alignment visual metrics computational ai-generated images
BDNF Val66Met moderates episodic memory decline and tau biomarker increases in early sporadic Alzheimer’s disease
sporadic tau d = 0 changes neurotrophic bdnf memory val66met csf disease ad decline alzheimer’s
Barriers to early diagnosis of cervical cancer: a mixed-method study in Côte d’Ivoire, West Africa
health study access screening qualitative data women côte d’ivoire cancer cervical diagnosis